157 related articles for article (PubMed ID: 34519585)
1. Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
Zhong M; Zhang Y; Pan Z; Wang W; Zhang Y; Weng Y; Huang H; He Y; Liu O
Technol Cancer Res Treat; 2021; 20():15330338211041465. PubMed ID: 34519585
[No Abstract] [Full Text] [Related]
2. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
[TBL] [Abstract][Full Text] [Related]
3. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
Seemann MD; Beinert T; Fürst H; Fink U
Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
[TBL] [Abstract][Full Text] [Related]
6. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
Chen X; Wang X; He H; Liu Z; Hu JF; Li W
PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
[TBL] [Abstract][Full Text] [Related]
7. [Value of Combined Detection of Cytokines and Tumor Markers in the
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
Ni LF; Liu XM
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
[TBL] [Abstract][Full Text] [Related]
10. Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.
Zhang W; Duan X; Zhang Z; Yang Z; Zhao C; Liang C; Liu Z; Cheng S; Zhang K
JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33905377
[TBL] [Abstract][Full Text] [Related]
11. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
12. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
[TBL] [Abstract][Full Text] [Related]
13. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
14. Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study.
He Y; Shi J; Shi G; Xu X; Liu Q; Liu C; Gao Z; Bai J; Shan B
Sci Rep; 2017 Aug; 7(1):9542. PubMed ID: 28842574
[TBL] [Abstract][Full Text] [Related]
15. [Research Progresses of Circulating Tumor Cells in Diagnosis and Treatment of
Early Lung Cancer].
Duan X; Liu Z; Xu S
Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):703-709. PubMed ID: 29061218
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of conventional tumor markers in young patients with pulmonary nodules.
Xu L; Su Z; Xie B
J Clin Lab Anal; 2021 Sep; 35(9):e23912. PubMed ID: 34296781
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer.
Dong J; Zhu D; Tang X; Lu D; Qiu X; Li B; Lin D; Li L; Liu J; Zhou Q
PLoS One; 2019; 14(7):e0220306. PubMed ID: 31348821
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Circulating Tumor Cells in Predicting Therapeutic Response in Small Cell Lung Cancer Patients.
Wang X; Ma K; Wang Y; He H; Hu JF; Li W
Arch Med Res; 2016 Aug; 47(6):454-459. PubMed ID: 27986125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
